These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 825907)

  • 1. Effects of cholinergic agonists and antagonists on morphine-withdrawal syndrome.
    Hynes MD; Gianutsos G; Lal H
    Psychopharmacology (Berl); 1976 Sep; 49(2):191-5. PubMed ID: 825907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cholinergic drugs on acute and chronic morphine dependence.
    Padmanabha Pillai N; Ramaswamy S; Gopalakrishnan V; Ghosh MN
    Arch Int Pharmacodyn Ther; 1982 May; 257(1):146-54. PubMed ID: 7202346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cholinergic and anticholinergic drugs and a partial cholinergic agonist on the development and expression of physical dependence on morphine in rat.
    Frederickson RC; Pinsky C
    J Pharmacol Exp Ther; 1975 Apr; 193(1):44-55. PubMed ID: 1169318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of cholinergic systems in the expression of morphine withdrawal.
    Sharif SI; el-Kadi AO
    Neurosci Res; 1996 Jun; 25(2):155-60. PubMed ID: 8829152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic mechanisms in precipitated withdrawal in morphine-dependent rats.
    Ary M; Cox B; Lomax P
    J Pharmacol Exp Ther; 1977 Feb; 200(2):271-6. PubMed ID: 557107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of morphine-withdrawal body shakes by a conditional stimulus in the rat.
    Numan R; Smith N; Lal H
    Psychopharmacol Commun; 1975; 1(3):295-303. PubMed ID: 1241454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of precipitated withdrawal symptoms by activating central cholinergic systems during a dependence-producing schedule of morphine in rats.
    Buccafusco JJ; Zhang LC; Shuster LC; Jonnala RR; Gattu M
    Brain Res; 2000 Jan; 852(1):76-83. PubMed ID: 10661498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ontogeny of morphine withdrawal in the rat.
    Jones KL; Barr GA
    Behav Neurosci; 1995 Dec; 109(6):1189-98. PubMed ID: 8748967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of lofexidine in blocking morphine-withdrawal signs in the rat.
    Shearman GT; Lal H; Ursillo RC
    Pharmacol Biochem Behav; 1980 Apr; 12(4):573-5. PubMed ID: 7190295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the inhibitory effects of clonidine and guanfacine on the behavioral and autonomic components of morphine withdrawal in rats.
    Buccafusco JJ; Marshall DC; Turner RM
    Life Sci; 1984 Sep; 35(13):1401-8. PubMed ID: 6148677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of beta-adrenoceptors in the expression of morphine withdrawal signs.
    Funada M; Suzuki T; Sugano Y; Tsubai M; Misawa M; Ueda H; Misu Y
    Life Sci; 1994; 54(8):PL113-8. PubMed ID: 7509021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of delta-opioid receptors in mediating the aversive stimulus effects of morphine withdrawal in the rat.
    Funada M; Schutz CG; Shippenberg TS
    Eur J Pharmacol; 1996 Apr; 300(1-2):17-24. PubMed ID: 8741160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphine tolerance and physical dependence: influence of cholinergic agonists and antagonists.
    Bhargava HN; Way EL
    Eur J Pharmacol; 1976 Mar; 36(1):79-88. PubMed ID: 944135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of naloxone-induced withdrawal signs by dextromethorphan in morphine-dependent mice.
    Farzin D
    Eur J Pharmacol; 1999 Jul; 377(1):35-42. PubMed ID: 10448923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspects of abstinence after morphine ingestion.
    Rönnbäck L; Eriksson PS; Zeuchner J; Rosengren L; Wronski A
    Pharmacol Biochem Behav; 1987 Sep; 28(1):87-93. PubMed ID: 3659110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Injection of Gamma-Aminobutyric Acid Agonists into the Nucleus Accumbens on Naloxone-Induced Morphine Withdrawal.
    Topkara B; Yananli HR; Sakallı E; Demirkapu MJ
    Pharmacology; 2017; 100(3-4):131-138. PubMed ID: 28637045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focal kappa-opioid receptor-mediated dependence and withdrawal in the nucleus paragigantocellularis.
    Sinchaisuk S; Ho IK; Rockhold RW
    Pharmacol Biochem Behav; 2002 Dec; 74(1):241-52. PubMed ID: 12376173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in sensitivity to operant effects of dopaminergic and cholinergic agents following morphine withdrawal in rats.
    Glick SD; Cox RD
    Eur J Pharmacol; 1977 Apr; 42(3):303-6. PubMed ID: 558097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid antagonists differ according to negative intrinsic efficacy in a mouse model of acute dependence.
    Walker EA; Sterious SN
    Br J Pharmacol; 2005 Aug; 145(7):975-83. PubMed ID: 15912139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further studies of the role of opioid receptors in the nigra in the morphine withdrawal syndrome.
    Baumeister AA; Richard AL; Richmond-Landeche L; Hurry MJ; Waguespack AM
    Neuropharmacology; 1992 Sep; 31(9):835-41. PubMed ID: 1359441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.